This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Charles Marwick

JAMA. 2000;283:1280-1281.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Bethesda, Md—Combination vaccines containing several antigenic components, making a single dose do double or triple duty, are essential if physicians are to take full advantage of new vaccines being developed to treat childhood diseases, but the road to their full clinical use needs some new markers. This was the essential conclusion from a meeting at the National Institutes of Health (NIH) on issues facing the development and licensure of new combination vaccines.

The thrust behind developing new combination vaccines to supplement the ones already in use is that the number of injections now in or to be added to the pediatric immunization schedule is imposing an unacceptable burden on physicians and parents. The current schedule calls for giving a child 15 to 19 injections by 6 years of age—12 of them in the first 18 months of life (JAMA. 2000;283:876-878). And shortly after the Bethesda . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?